The Next Generation Of Biodefense: AI, CRISPR & Rapid Diagnostics | Jared Bauer - CEO, Seek Labs

Episode notes

Send us Fan Mail What if the next pandemic could be identified, diagnosed, and targeted with programmable CRISPR therapeutics before it spreads globally? That’s exactly what Seek Labs is trying to build. Jared Bauer is CEO of Seek Labs ( ), a clinical-stage TechBio company developing an integrated platform that combines AI-driven genomic intelligence, rapid field diagnostics, and CRISPR-based therapeutics designed to identify and potentially counter emerging pathogens faster than ever before. In a world where outbreaks can spread globally before traditional systems even identify the threat - as we saw with COVID and more recently with delayed hantavirus confirmation cases - Seek Labs is asking a bold question: what if diagnostics and therapeutics could be programmed and deployed at the speed of software? Jared is also Chairman of BioHive Utah ( ), one of the fastest-growing life science ecosystems in the United States, and has spent his career at the intersection of biotech innovation, AI, diagnostics, and public health preparedness.

Related episodes across the Index

Other episodes covering the same guests and topics, from across The B2B Podcast Index.

• The Scientist Turned VC Funding the Cure for Aging with Omri Amirav-DroryVentures from The Valley · on Biotech81 / 100
• The Frontier State of Nonprofit AcceleratorsThe Frontier State Podcast · on Biotech78 / 100
• Deep Tech Gold Rush: Smart Boom or Future Bust?Venture Unlocked · on Biotech71 / 100
• 184. The Multiverse of Microbes: Henry Lee on Building Cultivarium and Training with TitansGrow Everything Biotech Podcast · on CRISPR65 / 100
• #113 - What was Fred Hoch from TechNexus doing in his 20sinTheir20s · on Biotech57 / 100
• Solving Patient Matching in Rare Disease TrialsP4A Let's Talk Rare: The Life Science Podcast · on CRISPR56 / 100

• Building the Internet of Medicine: How AI Could Transform Children's Healthcare | Dr. Timothy Chou - Founder, Pediatric Moonshot92 / 100
• The Blood Test That Could Change Cancer Treatment Forever | Eric Matthews - General Manager, Biopharma, Natera65 / 100
• How Female Biology Shapes Skin Disease Across a Lifetime | Dr. Doral Fredericks, PharmD, MBA - Vice President and Head of Global Medical Affairs and Outcomes Research, Organon56 / 100
• 55 Years Without a Diagnosis | Can AI Solve The Undiagnosed Condition Blind Spot? | Haresh Patel - Founder and CEO, Sanare Health AI70 / 100
• How Regenerative Medicine Is Reinventing Breast Reconstruction | Dr. Claudia Chavez-Munoz, MD, PhD - Chief Scientific Officer and Co-Founder - Conexeu Sciences